| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/J.AUTREV.2015.01.012 |
| P698 | PubMed publication ID | 25617818 |
| P50 | author | Jaume Alijotas-Reig | Q46803599 |
| Laura Andreoli | Q61806166 | ||
| Angela Tincani | Q73304219 | ||
| Arsène Mékinian | Q88043776 | ||
| Amelia Ruffatti | Q92104506 | ||
| Olivier Fain | Q114301300 | ||
| Valentina Canti | Q114416232 | ||
| Ma Tiziana Bertero | Q114417396 | ||
| Maria Grazia Lazzaroni | Q114417402 | ||
| Katarina Bremme | Q117237626 | ||
| Pascale Nicaise-Roland | Q117237627 | ||
| P2093 | author name string | Lionel Carbillon | |
| Robin Dhote | |||
| Pierre Levy | |||
| Holy Bezanahary | |||
| Francois Maurier | |||
| Amélie Benbara | |||
| Anna Kuzenko | |||
| Ahmed Tigazin | |||
| SNFMI and the European Forum on Antiphospholipid Antibodies | |||
| P433 | issue | 6 | |
| P921 | main subject | hydroxychloroquine | Q421094 |
| multicenter clinical trial | Q6934595 | ||
| P304 | page(s) | 498-502 | |
| P577 | publication date | 2015-01-21 | |
| P1433 | published in | Autoimmunity Reviews | Q15754966 |
| P1476 | title | The efficacy of hydroxychloroquine for obstetrical outcome in anti-phospholipid syndrome: Data from a European multicenter retrospective study | |
| P478 | volume | 14 |
| Q38876334 | Additional Treatments for High-Risk Obstetric Antiphospholipid Syndrome: a Comprehensive Review |
| Q96304889 | An update on the management of antiphospholipid syndrome |
| Q64046338 | Antiphospholipid syndrome |
| Q91390119 | Antiphospholipid syndrome - an update |
| Q38410376 | Antiphospholipid syndrome: an update |
| Q38679842 | Antiphospholipid syndrome: an update for clinicians and scientists |
| Q58602902 | Antiphospholipid syndrome: state of the art on clinical practice guidelines |
| Q55479438 | Arterial/venous thrombosis, fetal loss and stillbirth in pregnant women with systemic lupus erythematosus versus primary and secondary antiphospholipid syndrome: a systematic review and meta-analysis. |
| Q41915133 | Complement inhibition by hydroxychloroquine prevents placental and fetal brain abnormalities in antiphospholipid syndrome |
| Q54218397 | Current and Future Use of Chloroquine and Hydroxychloroquine in Infectious, Immune, Neoplastic, and Neurological Diseases: A Mini-Review. |
| Q38654271 | Do adverse pregnancy outcomes contribute to accelerated cardiovascular events seen in young women with systemic lupus erythematosus? |
| Q33731711 | EULAR recommendations for women's health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome |
| Q38782057 | Emerging Therapies in Antiphospholipid Syndrome |
| Q38954367 | Female Infertility and Serum Auto-antibodies: a Systematic Review. |
| Q37266831 | Hepatic infarction in a pregnant woman with antiphospholipid syndrome and triple antibody positivity: A case report focusing on catastrophic antiphospholipid syndrome |
| Q90157934 | Hydroxychloroquine Blood Levels Predict Hydroxychloroquine Retinopathy |
| Q64069038 | Hydroxychloroquine for prevention of recurrent miscarriage: study protocol for a multicentre randomised placebo-controlled trial BBQ study |
| Q90115791 | Idiopathic Normal Pressure Hydrocephalus - What We Know |
| Q38883883 | Immunomodulators in SLE: Clinical evidence and immunologic actions |
| Q87866782 | Immunosuppression in pregnant women with renal disease: review of the latest evidence in the biologics era |
| Q50640109 | Lymphocyte Disturbances in Primary Antiphospholipid Syndrome and Application to Venous Thromboembolism Follow-Up. |
| Q64910478 | Management of thrombotic and obstetric antiphospholipid syndrome: a systematic literature review informing the EULAR recommendations for the management of antiphospholipid syndrome in adults. |
| Q93060997 | Managing antiphospholipid syndrome in pregnancy |
| Q60938900 | Mechanisms of Endothelial Dysfunction in Antiphospholipid Syndrome: Association With Clinical Manifestations |
| Q55440072 | Nonbacterial thrombotic endocarditis in a patient with primary antiphospholipid syndrome. |
| Q39198671 | Pathogenesis and management of antiphospholipid syndrome |
| Q90115787 | Pregnancy Management in Women with Antiphospholidic Syndrome |
| Q38891094 | Pregnancy Outcome in Women with Obstetric and Thrombotic Antiphospholipid Syndrome-A Retrospective Analysis and a Review of Additional Treatment in Pregnancy. |
| Q65001423 | Pregnancy outcomes in patients with primary antiphospholipid syndrome: A systematic review and meta-analysis. |
| Q96686028 | Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria |
| Q55004116 | Risk Factors for Adverse Maternal and Fetal Outcomes in Women With Confirmed aPL Positivity: Results From a Multicenter Study of 283 Pregnancies. |
| Q45873335 | The effect of hydroxychloroquine on haemostasis, complement, inflammation and angiogenesis in patients with antiphospholipid antibodies |
| Q93047783 | Triple Antiphospholipid (aPL) Antibodies Positivity Is Associated With Pregnancy Complications in aPL Carriers: A Multicenter Study on 62 Pregnancies |
| Q35915182 | Unexplained Recurrent Miscarriage and Recurrent Implantation Failure: Is There a Place for Immunomodulation? |
| Q52654857 | Update on Antiphospholipid Syndrome: Ten Topics in 2017. |
Search more.